Vickie Reed

Vickie Reed joined Mirati Therapeutics, Inc. in 2013 and was appointed Chief Accounting Officer in 2020. She is a seasoned financial executive with broad financial and accounting leadership experience across both public and private companies, as well as having Big 4 public accounting experience. Vickie has a track record of building high-performing teams and collaborating with colleagues across the organization, bringing a strategic focus to business decisions.  

Prior to Mirati, Vickie served as Senior Director of Finance and Controller at Zogenix, Inc. Earlier in her career, she held corporate accounting positions at Amylin Pharmaceuticals, Inc. and financial leadership roles at several biotechnology and telecommunications companies. She began her career with Price Waterhouse, now PricewaterhouseCoopers, in Denver, Colorado.

Vickie received a B.S. in accounting from University of Colorado Denver.